EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

HybridMolGen: a unified framework for goal-directed molecular generation via multi-objective reinforcement learning

Masoud Amiri iD, Zahra Nasirinia

Bioinformatics · 03.05.2026 · 42 (5)

DOI: 10.1093/bioinformatics/btag170 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioinformatics, online erschienen am 04.04.2026. Verfasst von Masoud Amiri und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, 6715847141, Iran. Hauptthemen laut MEDLINE: Drug Discovery, Deep Learning. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Motivation De novo molecular design remains a fundamental challenge in drug discovery, requiring simultaneous optimization of multiple conflicting objectives such as drug-likeness, synthetic accessibility, and novelty while maintaining chemical validity. We present HybridMolGen, a novel unified framework that synergistically combines three complementary deep learning paradigms: (1) diffusion probabilistic models that generate high-quality, chemically valid molecular samples through gradual noise removal, (2) SE(3)-equivariant graph neural networks that enforce geometric and topological constraints ensuring structural validity and molecular diversity, and (3) property-conditioned transformers that enable fine-grained control over multiple objectives through multi-layer cross-attention modulation. Results These components operate within a multi-objective reinforcement learning paradigm that discovers optimal property tradeoffs without manual weight tuning. Extensive benchmarking on MOSES, GuacaMol, and ZINC-250k datasets demonstrates state-of-the-art performance: 99.7% validity, 94.3% novelty, average QED score of 0.753, and 4.9% improvement in GuacaMol overall scores. Critically, HybridMolGen discovers 1.57× more molecules satisfying all target criteria simultaneously (91.3% versus 58.3% for CPRL) and generates 2.23× more Pareto-efficient solutions compared to traditional scalarization, demonstrating genuine architectural synergy beyond simple component aggregation. Comprehensive ablation studies confirm that the three-way integration outperforms even the best two-component combination by 6.5%, positioning HybridMolGen as a powerful tool for accelerating drug discovery pipelines. Availability and implementation Implementation code is available as Supplementary Material, available as supplementary data at Bioinformatics online.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug DiscoveryDeep LearningReinforcement Machine LearningAlgorithmsGraph Neural Networks

Autor:innen und Institutionen

  • Department of Biomedical Engineering, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, 6715847141, Iran.

ORCID-Profile: Masoud Amiri

Zitieren

APA

Amiri, M., & Nasirinia, Z. (2026). HybridMolGen: a unified framework for goal-directed molecular generation via multi-objective reinforcement learning. Bioinformatics, 42(5). https://doi.org/10.1093/bioinformatics/btag170

Vancouver

Amiri M, Nasirinia Z. HybridMolGen: a unified framework for goal-directed molecular generation via multi-objective reinforcement learning. Bioinformatics. 2026;42(5). doi:10.1093/bioinformatics/btag170

BibTeX
@article{Amiri2026,
  author = {Amiri, Masoud and Nasirinia, Zahra},
  title = {HybridMolGen: a unified framework for goal-directed molecular generation via multi-objective reinforcement learning},
  journal = {Bioinformatics},
  year = {2026},
  volume = {42},
  number = {5},
  doi = {10.1093/bioinformatics/btag170}
}
Kostenlos starten →